News for Healthier Living

International Study Identifies Promising Therapy to Prevent Relapses in Rare Neurological Disease

An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

August 6, 2026


August 19 2026

August 18 2026

August 17 2026

August 16 2026

August 15 2026

August 14 2026

August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026